256 related articles for article (PubMed ID: 22925152)
1. Effects of androgen deprivation on brain function in prostate cancer patients - a prospective observational cohort analysis.
Chao HH; Uchio E; Zhang S; Hu S; Bednarski SR; Luo X; Rose M; Concato J; Li CS
BMC Cancer; 2012 Aug; 12():371. PubMed ID: 22925152
[TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
[TBL] [Abstract][Full Text] [Related]
3. Effects of androgen deprivation on cerebral morphometry in prostate cancer patients--an exploratory study.
Chao HH; Hu S; Ide JS; Uchio E; Zhang S; Rose M; Concato J; Li CS
PLoS One; 2013; 8(8):e72032. PubMed ID: 23977199
[TBL] [Abstract][Full Text] [Related]
4. Anaemia following initiation of androgen deprivation therapy for metastatic prostate cancer: a retrospective chart review.
Curtis KK; Adam TJ; Chen SC; Pruthi RK; Gornet MK
Aging Male; 2008 Dec; 11(4):157-61. PubMed ID: 18937151
[TBL] [Abstract][Full Text] [Related]
5. Degarelix versus goserelin plus bicalutamide therapy for lower urinary tract symptom relief, prostate volume reduction and quality of life improvement in men with prostate cancer: a systematic review and meta-analysis.
Cui Y; Zong H; Yan H; Li N; Zhang Y
Urol Int; 2014; 93(2):152-9. PubMed ID: 24603064
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Function in Patients With Prostate Cancer Receiving Luteinizing Hormone-Releasing Hormone Analogues: A Prospective, Observational, Multicenter Study.
Morote J; Tabernero ÁJ; Álvarez Ossorio JL; Ciria JP; Domínguez-Escrig JL; Vázquez F; Angulo J; López FJ; de La Iglesia R; Romero J;
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):590-594. PubMed ID: 28581399
[TBL] [Abstract][Full Text] [Related]
7. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
[TBL] [Abstract][Full Text] [Related]
8. Subjective and Objective Effects of Androgen Ablation Therapy on Voice.
Salturk Z; Çakır O; Kumral TL; Yıldırım G; Ötünçtemur A; Aydoğdu Ï; Uyar Y
J Voice; 2015 Jul; 29(4):490-3. PubMed ID: 25704476
[TBL] [Abstract][Full Text] [Related]
9. Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.
Deka R; Rose BS; Bryant AK; Sarkar RR; Nalawade V; McKay R; Murphy JD; Simpson DR
Cancer; 2019 Apr; 125(7):1070-1080. PubMed ID: 30748008
[TBL] [Abstract][Full Text] [Related]
10. Depression related to (neo)adjuvant hormonal therapy for prostate cancer.
van Tol-Geerdink JJ; Leer JW; van Lin EN; Schimmel EC; Stalmeier PF
Radiother Oncol; 2011 Feb; 98(2):203-6. PubMed ID: 21256610
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.
Haque R; UlcickasYood M; Xu X; Cassidy-Bushrow AE; Tsai HT; Keating NL; Van Den Eeden SK; Potosky AL
Br J Cancer; 2017 Oct; 117(8):1233-1240. PubMed ID: 29017178
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation in prostate cancer and the long-term risk of fracture.
Ojeda S; Lloret M; Naranjo A; Déniz F; Chesa N; Domínguez C; Lara PC
Actas Urol Esp; 2017 Oct; 41(8):491-496. PubMed ID: 28259363
[TBL] [Abstract][Full Text] [Related]
13. Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values.
Wadhwa VK; Weston R; Mistry R; Parr NJ
BJU Int; 2009 Sep; 104(6):800-5. PubMed ID: 19338564
[TBL] [Abstract][Full Text] [Related]
14. DCE and DW MRI in monitoring response to androgen deprivation therapy in patients with prostate cancer: a feasibility study.
Barrett T; Gill AB; Kataoka MY; Priest AN; Joubert I; McLean MA; Graves MJ; Stearn S; Lomas DJ; Griffiths JR; Neal D; Gnanapragasam VJ; Sala E
Magn Reson Med; 2012 Mar; 67(3):778-85. PubMed ID: 22135228
[TBL] [Abstract][Full Text] [Related]
15. Long-term quality of life outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with androgen deprivation.
Luo HC; Cheng LP; Cheng HH; Fu ZC; Liao SG; Li DS; Zheng WF; Lin GS; Zhu JF; Xu JF; Yin Q; Yu QY
Med Oncol; 2014 Jun; 31(6):991. PubMed ID: 24848281
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the lipid profile and atherogenic risk during androgen deprivation therapy in prostate cancer patients.
Salvador C; Planas J; Agreda F; Placer J; Trilla E; Lopez MA; Morote J
Urol Int; 2013; 90(1):41-4. PubMed ID: 23235105
[TBL] [Abstract][Full Text] [Related]
17. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer.
Chu FM; Sartor O; Gomella L; Rudo T; Somerville MC; Hereghty B; Manyak MJ
Eur J Cancer; 2015 Aug; 51(12):1555-69. PubMed ID: 26048455
[TBL] [Abstract][Full Text] [Related]
18. Response of the insulin-like growth factor (IGF) system to IGF-IR inhibition and androgen deprivation in a neoadjuvant prostate cancer trial: effects of obesity and androgen deprivation.
Dean JP; Sprenger CC; Wan J; Haugk K; Ellis WJ; Lin DW; Corman JM; Dalkin BL; Mostaghel E; Nelson PS; Cohen P; Montgomery B; Plymate SR
J Clin Endocrinol Metab; 2013 May; 98(5):E820-8. PubMed ID: 23533230
[TBL] [Abstract][Full Text] [Related]
19. An unusual case of "sterile" abscess within low-grade meningioma during anti androgenic therapy and LH-releasing hormone agonist treatment for prostate cancer.
Fabbri VP; Asioli S; Palandri G
Clin Neurol Neurosurg; 2020 Sep; 196():105993. PubMed ID: 32563976
[No Abstract] [Full Text] [Related]
20. Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer.
Nguyen PL; Jarolim P; Basaria S; Zuflacht JP; Milian J; Kadivar S; Graham PL; Hyatt A; Kantoff PW; Beckman JA
J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25896892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
